XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Adjustments to reconcile net loss to net cash used in operating activities;    
Gain on sale of equipment $ (84,496) $ 428,714
Stock based compensation 31,581 32,353
Changes in Assets and Liabilities    
Decrease in accounts receivable 155,019 (68,446)
Decrease in inventories (98,254) (166,683)
Increase (decrease) in accounts payable (384,896) (46,176)
Increase in accrued expenses (305,281) 125,954
Decrease in fair value of warrants and convertible feature of long term debt (32,344)
NET CASH USED IN OPERATING ACTIVITES (589,823) 554,387
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of equipment (212,487) (1,925,577)
Proceeds from sale of fixed assets
Decrease in license fees (20,250)
Net cash Used in Investing activities (232,737) (1,925,577)
CASH FLOWS FROM FINANCING ACTIVITIES    
Net proceeds from issuance of Notes 990,000 2,079,131
Net proceeds from issuance of Series A Nonvoting Capital Stock (265,864) (416,028)
Net cash provided by financing activities 724,136 1,663,103
Net Increase (Decrease) in Cash (98,424) 291,913
Cash - Beginning of period 1,598,749 565,461
Cash - End of period 1,500,325 857,374
Supplemental Disclosure of Non-Cash Financing Activities:    
Issuance of nonvoting common stock (265,864) (416,028)
Inventory transferred to fixed assets 30,000 125,005
Cash paid for interest $ 375,377 $ 217,123